Article Text

Download PDFPDF

P11.31 Hiv/sti prevalence, sexual risk, and drug use among men who have sex with men in urban settings in viet nam
Free
  1. DC Thanh,
  2. TD Quang,
  3. LA Tuan,
  4. NTT Ha,
  5. HTT Ha,
  6. HT Tram,
  7. PH Thang,
  8. NA Tuan
  1. National Institute of Hygiene and Epidemiology, Ha Noi, Viet Nam

Abstract

Introduction HIV epidemic is still concentrated in most at risk populations including people who inject drugs (PWID), female sex workers (FSW), and men who have sex with men (MSM) in Viet Nam. This aims to describe HIV/STI prevalence and drug use among MSM in Ha Noi, Hai Phong, and Can Tho, Viet Nam.

Methods Cross-sectional surveys were conducted among MSM in 2013. Biologic and behavioural data were collected with the main objectives of obtaining HIV/STI prevalence, risk and preventive behaviours which focused on sexual and drug-using behaviours and exposure to HIV/AIDS intervention programs.

Results HIV prevalence was 4.0%, 5.4%, and 1.1% in Ha Noi, Hai Phong, and Can Tho, respectively. Chlamydia Trachomatis (CT) was 4.4%, 5.0%, and 3.5% in Ha Noi, Hai Phong, and Can Tho, respectively. Neisseria Gonorrhoea (NG) was 3.4%, 0.3%, and 3.2% in rectal and 0.0%, 0.3%, and 0.9% in genital in Ha Noi, Hai Phong, and Can Tho, respectively. Consistently condom use with non-commercial male partners in past month was 59.1%, 78.6%, and 62.3% in Ha Noi, Hai Phong, and Can Tho, respectively. Reported ever drug use was 13.2%, 13.1%, and 1.5% in Ha Noi, Hai Phong, and Can Tho, respectively. Opiate in urinalysis was 5.3%, 11.0%, and 1.2% in Ha Noi, Hai Phong, and Can Tho, respectively. Amphetamine-type stimulants (ATS) positive in urinalysis was 2.8%, 0.7%, and 0.0% in in Ha Noi, Hai Phong, and Can Tho, respectively.

Conclusion HIV prevalence was relatively high in Ha Noi and Hai Phong. There was an evidence of unsafe sex since the presence of other STIs. Non-injection drug use, particularly ATS use, among MSM has gained increasing attention. HIV prevention efforts need a refocus on sexual and drug using risk reduction for MSM.

Disclosure of interest None.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.